Newsroom

June 10, 2026

Lifespan Portfolio Company Matter Bio Announces FDA IND Clearance

Read More
June 8, 2026

Lifespan Portfolio Company Rejuvenate Bio Announces Financing and Strategic Collaboration with Merck Animal Health

Read More
May 18, 2026

Lifespan Vision Ventures Leads Violet Therapeutics' $4.75M Seed Extension Round

Read More
May 7, 2026

LIfT Biosciences Establishes Scientific Advisory Board, including Nobel Laureate James Allison

Read More
May 4, 2026

Daewoong Pharmaceutical and FreeMind Investments Invest in General Proximity

Read More
March 19, 2026

Lifespan Portfolio Company Fauna Bio Announces Target Designation Milestone in Obesity Partnership

Read More
January 14, 2026

Lifespan Portfolio Company Immunis Announces Phase 2 Preliminary Results

Read More
November 13, 2025

Lifespan Portfolio Company General Proximity Announces Multi-Target Collaboration with Daiichi Sankyo

Read More
October 6, 2025

Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery

Read More
September 26, 2025

Lifespan portfolio company Modulo Bio featured in video with Eli Lilly Gateway Labs

Read More
September 24, 2025

Remedium signs multi-target gene therapy deal with Eli Lilly

Read More
June 29, 2025

Lifespan Portfolio Company LIfT Biosciences Announces €12M Grant to Fund First-In-Human Clinical Trial

Read More
June 13, 2025

Lifespan Portfolio Company SENISCA Announces Partnership with L'Oreal

Read More
March 19, 2025

Lifespan Portfolio Company Modulo Bio Receives $4.8M from the Alzheimer's Drug Discovery Foundation

Read More
March 4, 2025

Lifespan Portfolio Company Immunis Doses First Patients in Phase 2 Clinical Trial

Read More
January 6, 2025

Lifespan-backed General Proximity emerges from stealth

Read More
December 10, 2024

Lifespan Portfolio Company Integrated Biosciences Announces Partnership with LVMH Recherche

Read More
October 3, 2024

Integrated Biosciences Raises $17 Million to Accelerate Development of Drugs Targeting Age-Related Diseases

Read More
September 24, 2024

LIfT BioSciences raises £10m in first close of Series A to advance first-in-class allogeneic innate cell therapy

Read More
September 11, 2024

LifeSpan Vision Featured In FINSMES "Remedium Bio Receives Investment from LifeSpan Vision Ventures"

Read More
September 10, 2024

LifeSpan Vision Featured In PR Newswire "LifeSpan Vision Ventures Invests in Remedium Bio"

Read More
September 10, 2024

LifeSpan Vision Featured In Yahoo Finance "LifeSpan Vision Ventures Invests in Remedium Bio"

Read More
May 29, 2024

LifeSpan Vision Featured In PR Newswire "Matter Bio Successfully Closes $7M Seed Funding Round"

Read More
May 29, 2024

LifeSpan Vision Featured In Longevity "Matter Bio lands seed funding for longevity therapeutics that preserve genomic integrity"

Read More
March 1, 2024

SENISCA secures additional £3.7 million financing to support rapid development of senotherapeutic platform

Read More
December 21, 2023

Lifespan Portfolio Company Fauna Bio Announces Partnership with Eli Lilly worth $494M

Read More
October 31, 2023

LifeSpan Vision Featured In FINSMES "NaNotics Receives Investment From LifeSpan Vision Ventures"

Read More
October 16, 2023

LifeSpan Vision Featured In WestFair "Norwalk’s LifeSpan Vision Ventures Invests in Rejuvenation Technologies"

Read More
October 3, 2023

LifeSpan Vision Featured In BioSpace "LifeSpan Vision Ventures Invests in Deciduous Therapeutics"

Read More
April 5, 2022

LifeSpan Vision Featured In FOX59 "LifeSpan Vision Ventures Launched To Focus On Longevity And Aging Reversal"

Read More

Get updates from the LifeSpan Vision team

AboutPORTFOLIONEWSCONTACT
©
LifeSpan Vision Ventures — Norwalk, Connecticut. — Privacy Policy | Terms of use